I.H. Hall
- Cancer Research top 10%
- Sesquiterpenes and Asteraceae Studies 10
- Organic Chemistry top 5%
- Organoboron and organosilicon chemistry 6
- Toxicology top 5%
- Molecular Biology top 10%
- Biochemical and Molecular Research 14
- Cancer therapeutics and mechanisms 12
- Mitochondrial Function and Pathology 7
- Biochemistry top 10%
-
- Metabolism and Genetic Disorders 7
-
- HIV/AIDS drug development and treatment 7
-
- Boron Compounds in Chemistry 7
- Co-authors
- K.H. LeeBernard F. SpielvogelC.O. StarnesThomas K. WaddellMia MillerYoichi SumidaRong-Yang WuD.X. West
- Journals
- Journal of Pharmaceutical Sciences (33 papers)Experimental Biology and Medicine (5 papers)Anti-Cancer Drugs (3 papers)
- Partner nations
- United StatesSerbiaUnited Kingdom
In The Last Decade
I.H. Hall
81 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 109
- Cancer Research 270
- Organic Chemistry 472
- Toxicology 39
- Molecular Biology 718
- Biochemistry 75
Countries citing papers authored by I.H. Hall
This map shows the geographic impact of I.H. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I.H. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I.H. Hall more than expected).
Fields of papers citing papers by I.H. Hall
This network shows the impact of papers produced by I.H. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I.H. Hall. The network helps show where I.H. Hall may publish in the future.
Co-authorship network
The 25 scholars most cited alongside I.H. Hall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cytotoxicity of 2-ethenyl-2,3-dihydrophthalazine-1,4-diones in murine and human tumor cultured cells. | 2001 | 2 |
| 2 | 1999 | 1 | |
| 3 | 1997 | 5 | |
| 4 | 1996 | 5 | |
| 5 | 1995 | 10 | |
| 6 | 1994 | 15 | |
| 7 | 1993 | 6 | |
| 8 | 1993 | 2 | |
| 9 | 1993 | 2 | |
| 10 | 1993 | 29 | |
| 11 | 1992 | 14 | |
| 12 | 1992 | 4 | |
| 13 | 1991 | 32 | |
| 14 | 1988 | 12 | |
| 15 | 1987 | 12 | |
| 16 | 1986 | 13 | |
| 17 | 1985 | 25 | |
| 18 | 1983 | 21 | |
| 19 | 1979 | 144 | |
| 20 | 1977 | 1 |
About I.H. Hall
I.H. Hall is a scholar working on Clinical Biochemistry, Biochemistry, Organic Chemistry, Molecular Biology and Cancer Research, having authored 82 papers that have together received 1.5k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (14 papers), Cancer therapeutics and mechanisms (12 papers), Sesquiterpenes and Asteraceae Studies (10 papers), Mitochondrial Function and Pathology (7 papers), Metabolism and Genetic Disorders (7 papers), HIV/AIDS drug development and treatment (7 papers), Boron Compounds in Chemistry (7 papers) and Organoboron and organosilicon chemistry (6 papers). The work is most often cited by research in Cancer Research (270 citations), Organic Chemistry (472 citations), Toxicology (39 citations), Molecular Biology (718 citations) and Biochemistry (75 citations). I.H. Hall has collaborated with scholars based in United States, Serbia and United Kingdom. Frequent co-authors include K.H. Lee, Bernard F. Spielvogel, C.O. Starnes, Thomas K. Waddell, Mia Miller, Yoichi Sumida, Rong-Yang Wu, D.X. West, Anup Sood and George H. Cocolas. Their work appears in journals such as Journal of Pharmaceutical Sciences, Experimental Biology and Medicine, Anti-Cancer Drugs, Applied Organometallic Chemistry and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.